The Impact of Vericiguat on Microvascular Function in Patients with Documented Vasospastic Angina Pectoris

NCT06415227 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Vasospastic Angina

Interventions

DRUG: Vericiguat

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborators

[object Object]